<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04306874</url>
  </required_header>
  <id_info>
    <org_study_id>19D.669</org_study_id>
    <nct_id>NCT04306874</nct_id>
  </id_info>
  <brief_title>Whipple Protein Study</brief_title>
  <acronym>WPS</acronym>
  <official_title>High-Protein Oral Nutritional Supplementation in Patients Undergoing Pancreaticoduodenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study investigators aim to assess the effect of providing high-protein nutritional
      supplementation before and after surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreaticoduodenectomy (PD) is a complex and morbid operation that is associated with many
      potential complications. Many people undergoing PD are malnourished due to their underlying
      medical condition or difficulties eating in the face of abdominal pain or obstruction from
      pancreatic disease. This study aims to assess the effect of high-protein dietary
      supplementation in improving perioperative nutrition and decreasing complications. We will
      randomize PD patients to an experimental arm in which they take a nutritional, high-protein
      supplement for 2 weeks before and after surgery, or to a control arm, where they will take a
      standard postoperative diet without supplementation. Outcomes and nutritional parameters will
      be examined after they complete the supplements.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel, non-blinded, randomized controlled two-arm trial: supplement vs. placebo</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>All complications within 30 days of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>6 months</time_frame>
    <description>Overall survival time since surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prealbumin level</measure>
    <time_frame>30 days</time_frame>
    <description>Serum prealbumin level (normal 15-36 mg/dL). Lower levels indicate acute malnutrition.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">172</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>High Protein Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 g total protein per day, administered via twice daily ensure max protein shakes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention on diet; routine dietary practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ensure Max Protein</intervention_name>
    <description>Liquid shake with 30 g protein per serving</description>
    <arm_group_label>High Protein Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing pancreaticoduodenectomy

          -  Patients aged 18 years and older

          -  Patients able to provide written informed consent

          -  Patients able to understand and comply with study guidelines

          -  Patients able to tolerate oral intake

          -  Patients who are malnourished or at risk of malnutrition as defined by a score less
             than 12 on the Mini-Nutritional Assessment

        Exclusion Criteria:

          -  Patients with a milk protein allergy

          -  Patients with a vegan diet

          -  Patients dependent on artificial enteral feeding

          -  Patients with end-stage renal disease undergoing dialysis

          -  Patients who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harish Lavu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Zheng, MD</last_name>
    <phone>6464278188</phone>
    <email>Rzheng4@gmail.com</email>
  </overall_contact>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2020</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pancreaticoduodenectomy</keyword>
  <keyword>surgery</keyword>
  <keyword>nutrition</keyword>
  <keyword>protein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

